Companies: 10,795·Total market cap: $144.5T
Instadose Pharma Corp.

Instadose Pharma Corp.

INSDOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$53193
P/E Ratio
52W High$0.0011
52W Low$0.0001
Overview

Instadose Pharma Corp. (INSD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · INSD · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.00insd eps ttm · insd earnings per shareEarnings history
PE Ratio (TTM)insd pe ratio ttm · insd price to earningsPE Ratio deep dive
Revenue (TTM)0.00insd revenue ttm · insd annual revenueFull revenue history
Dividend YieldNo Dividenddoes insd pay dividends · insd dividend yieldDividend history
Shares Outstanding75.0Minsd shares outstanding · insd floatShares outstanding history
Next EarningsTBAinsd earnings date · insd next earningsEarnings history

Financial Snapshot

Full Financials
FY 2021Revenue$0.00
201920202021
instadose pharma corp. revenue · insd revenue 2021
FY 2021Net Income-$589000.00▼ 1668.08% YoY
201920202021
instadose pharma corp. net income · insd profit 2021
FY 2021EPS$-0.00▼ 1500.00% YoY
201920202021
insd eps · instadose pharma corp. earnings per share 2021
TTM:Revenue: $0.00Net Income: -$1.7MEPS: $-0.00View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-90.91%
5Y-99.90%

About Instadose Pharma Corp.

CEOAntonio Rocco Franchino
IPO DateOct 27, 2020
Employees2
CountryUS

Instadose Pharma Corp. Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.

what is instadose pharma corp. · insd stock overview · instadose pharma corp. company profile · who is instadose pharma corp. ceo · insd OTC · instadose pharma corp. headquarters · instadose pharma corp. business segments

About Stock Overview & Key Data

Instadose Pharma Corp. (INSD) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Oct 27, 2020. As of the latest trading session, INSD stock price is $0.00, with a market capitalization of $53,193. The stock has returned -90.91% over the past 12 months and +0.00% year-to-date.

In fiscal year 2021, Instadose Pharma Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Instadose Pharma Corp. (INSD) stock price is $0.00. The stock is traded on OTC under the ticker symbol INSD. The 52-week range is $0.00 – $0.00.

INSD stock priceINSD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice